Medical Statistics and decision making
To develop and apply statistical and machine learning methods for analyzing ever-larger and complex data in collaboration with epidemiologists and clinicians.
Our research focuses on developing modern methods for statistical modeling in clinical and epidemiological studies and analyses of large cohort data. We also develop decision analysis techniques to support benefit-risk assessments of medicines and medical decision making. In addition to these research activities our unit teaches statistical methods to undergraduate and postgraduate students through a range of basic and advanced courses, and provides statistical support through the Clinical Research Office and through short- and long-term collaborations with various clinical departments in the UMCG.
In 2021 we plan to develop a new course focused on machine learning methods that are relevant for medical research, and launch several new e-learning modules for statistics courses . We will also explore how our risk assessment software ADDIS can support UMCG staff. Our research efforts in 2021 are focusing on developing methods for identify hidden patterns in Lifelines and UK Biobank data.
|Gerton Lunter||Full Professor, unit chair||g.a.lunter umcg.nl||Statistics and Machine Learning|
|Hans Hillege||Full Professor||h.hillege umcg.nl||Clinical Epidemiology|
|Sacha la Bastide||Assistant professor||s.la.bastide umcg.nl||Causal Inference|
|Hans Burgerhof||Lecturer||j.g.m.burgerhof umcg.nl||Teaching; study design|
|Douwe Postmus||Senior researcher||d.postmus umcg.nl||Medical decision making|
|Kata Tamasi||Statistical Consultant||k.tamasi umcg.nl||Medical Statistics|
|Daan Reid||Software engineer||d.reid umcg.nl||Decision Support Systems|
|Joris de Keijser||Software engineer||j.j.de.keijser umcg.nl||
Decision Support Systems
|Karlis Zalite||Software developer||k.zalite umcg.nl||
Decision Support Systems
|Yuntao Chen||Advanced survival analysis techniques||Advanced survival analysis techniques|
Developmental Neurology, Pediatrics, UMCG
Developmental outcomes of infants born with severecongenital heart disorder
|Sonia Roldan Munoz||Clinical pharmacy & pharmacology||s.roldan.munoz umcg.nl||Preference heterogenety in regulatory benefit-risk assessment|
|Klazien de Vries||Mathematics, Oncology||k.de.vries umcg.nl||Improved survival analysis using machine learning|
Re-design of the study data import process of the ADDIS software
|Last modified:||16 April 2021 6.02 p.m.|